Envarsus 750microgram modified-release tablets
BNF presentation 0802020T0BJABBD within chapter Malignant Disease and Immunosuppression. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Presentation code
0802020T0BJABBD
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
56
NHS spend (£)
£3,811.96
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 12 |
| December 2024 | 2 |
| November 2024 | 9 |
| October 2024 | 10 |
| July 2024 | 8 |
| May 2024 | 1 |
| June 2021 | 1 |
| December 2020 | 4 |
| November 2020 | 9 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 8 | No data available |
| Unknown pharmacy | 4 | No data available |
|
James Street Group Pract
ODS A82047
|
3 | 01H - NORTH EAST AND NORTH CUMBRIA ICB |
|
Leven & Beeford Medical Practice
ODS B81034
|
3 | 02Y - HUMBER AND NORTH YORKSHIRE ICB |
| Unknown pharmacy | 3 | No data available |
|
Jenner Healthcare
ODS D81022
|
3 | 06H - CAMBRIDGESHIRE & PETERBOROUGH ICB |
| Unknown pharmacy | 3 | No data available |
| Unknown pharmacy | 3 | No data available |
| Unknown pharmacy | 2 | No data available |
| Unknown pharmacy | 2 | No data available |